JPMorgan Chase & Co. Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price

Tempus AI (NASDAQ:TEM) had its price target reduced by investment analysts at JPMorgan Chase & Co. from $85.00 to $80.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 14.33% from the stock’s previous close.

Other research analysts have also recently issued research reports about the stock. TD Cowen cut shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price target on the stock. in a research note on Tuesday, October 21st. Guggenheim raised their target price on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 26th. Canaccord Genuity Group cut their price target on Tempus AI from $110.00 to $95.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. BTIG Research upped their price target on Tempus AI from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, November 25th. Finally, Cowen cut Tempus AI from a “buy” rating to a “hold” rating in a research report on Tuesday, October 21st. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Tempus AI currently has a consensus rating of “Hold” and a consensus price target of $85.36.

Tempus AI Trading Down 0.9%

TEM traded down $0.64 on Monday, hitting $69.97. 2,032,223 shares of the company were exchanged, compared to its average volume of 10,719,602. Tempus AI has a 12 month low of $31.36 and a 12 month high of $104.32. The stock has a market capitalization of $12.45 billion, a PE ratio of -58.80 and a beta of 5.00. The firm has a fifty day simple moving average of $80.97 and a two-hundred day simple moving average of $73.59. The company has a debt-to-equity ratio of 2.45, a quick ratio of 3.12 and a current ratio of 3.28.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. The business had revenue of $334.21 million during the quarter, compared to analyst estimates of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. Tempus AI’s revenue was up 84.7% compared to the same quarter last year. During the same period last year, the business earned ($0.46) EPS. Sell-side analysts expect that Tempus AI will post -6.15 earnings per share for the current year.

Insider Buying and Selling

In other Tempus AI news, EVP Andrew Polovin sold 12,874 shares of the firm’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $75.00, for a total value of $965,550.00. Following the transaction, the executive vice president owned 107,590 shares in the company, valued at approximately $8,069,250. This trade represents a 10.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Ryan Fukushima sold 10,099 shares of Tempus AI stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $65.54, for a total transaction of $661,888.46. Following the completion of the transaction, the chief operating officer owned 829,081 shares of the company’s stock, valued at $54,337,968.74. This trade represents a 1.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,097,780 shares of company stock worth $86,054,406 over the last ninety days. 26.27% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tempus AI

Several institutional investors have recently modified their holdings of TEM. Cranbrook Wealth Management LLC acquired a new position in Tempus AI during the 3rd quarter worth $25,000. Concord Wealth Partners increased its stake in shares of Tempus AI by 308.0% during the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock worth $26,000 after buying an additional 308 shares during the period. JPL Wealth Management LLC purchased a new stake in shares of Tempus AI during the 3rd quarter worth approximately $26,000. GAMMA Investing LLC acquired a new position in Tempus AI during the third quarter worth $28,000. Finally, Allworth Financial LP increased its position in Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company’s stock worth $29,000 after buying an additional 450 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.